Research Article
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
Figure 1
Survival outcomes in patients with sarcomatoid metastatic renal cell carcinoma (SmRCC). (a) Overall survival in SmRCC. (b) Progression-free survival of treated SmRCC. Overall survival stratified by MSKCC (c) and Heng risk criteria (d), extent of sarcomatoid component (e), and IMP3 staining (f).
| (a) Overall survival |
| (b) Progression-free survival |
| (c) MSKCC criteria |
| (d) Heng criteria |
| (e) Sarcomatoid component |
| (f) IMP3 |